NSB
NEUROSCIEN FPO [NSB]
Healthcare · ASX Small Cap
$0.0870 +6.1%
Updated 26 Mar 2026 · Scores refresh every scan
Score Breakdown
Technical59
Catalyst50
Sentiment50
Fundamental70
Momentum80
Risk Gate46
Get alerts when NSB's score changes
Free watchlist with daily scans for 2,200+ ASX stocks
Active Signals
Bullish Signals
- RSI drifting toward oversold territory — worth watching
- MACD momentum is picking up steam
- On a tear — up 11.5% over the last 5 days
- Volume-price trend says buyers are quietly accumulating — price hasn't caught up yet
- Volatility is expanding fast — choppy price action, so buckle up
- Strong cash runway (18 quarters)
- 4C filed 2026-01-29
- Very high P/S ratio (91.0x)
- Strong revenue growth (+129%)
- Small-cap ($20-100M)
- Sentiment is mixed — no strong consensus either way
- Strong long-term momentum — up 72% over the past year (excluding last month)
- Revenue growing at +129% — the top line is moving in the right direction
- The bigger volume days are the up days — volume-weighted momentum is positive (9.83%/day)
- Altman Z-Score grey zone (1.92, low-confidence approx)
- RBA hiking (-3pts)
Risk Signals
- Trading below both moving averages — the trend is working against this one
- Below the 200-day average — the long-term trend is still working against it
- Not enough chatter to gauge sentiment — defaulting to neutral
- Overseas neutral (-2pts, S&P500 neutral, VIX 25)
Ask Scout AI about NSB
3 free messages/day · Unlimited with Pro
Recent Catalysts
NONE StemSmart Manufacturing Scale-Up Transfer Advances
NONE Half Yearly Report and Accounts
NONE Company Presentation
LOW Quarterly Activities/Appendix 4C Cash Flow Report
Recent ASX Announcements
| 2026-03-16 | StemSmart Manufacturing Scale-Up Transfer Advances |
| 2026-02-25 | Half Yearly Report and Accounts PRICE SENSITIVE |
| 2026-02-15 | Company Presentation |
| 2026-01-29 | Quarterly Activities/Appendix 4C Cash Flow Report PRICE SENSITIVE |
Key Metrics
$28.9M
Market Cap
221K
Avg Volume
0.9x
Vol Ratio
$0.03 — $0.26
52-Week Range
N/A
Short Interest
18 qtrs
Cash Runway
-29.6%
ROE
N/A
Profit Margin
CANSLIM Analysis
| Factor | Rating | Detail | |
|---|---|---|---|
| C | Current EPS | fail | EPS Growth: 0% |
| A | Annual Earnings | fail | CAGR: 0% |
| N | New Highs / Catalysts | neutral | |
| S | Supply & Demand | neutral | Float: 73% |
| L | Leader vs Laggard | laggard | RS: -5 |
| I | Institutional Sponsorship | insufficient_data | Inst: 0% |
| M | Market Direction | neutral | Neutral |
Sector: Healthcare
Ranked #36 of 117 · Sector avg: 46
View all Healthcare signals →Track NSB and 2,200+ ASX stocks
Get free access to Scout's AI-powered dashboard with daily scans, watchlist alerts, and conviction scoring for every ASX small cap.
No credit card required